Meagan Raeke

Enhanced CAR T cell therapy offers new strategy for lymphoma

Image: iStock/Naeblys

Enhanced CAR T cell therapy offers new strategy for lymphoma

A new study from Penn Medicine marks a significant development in the ongoing evolution of CAR T cell therapy, as a novel cytokine-enhanced CAR T that has been tested in patients with blood cancer shows robust response rates.

2 min. read

Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer

Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer

A preclinical study from the Perelman School of Medicine and Penn Medicine’s Abramson Cancer Center that combines RAS inhibition and immunotherapy shows promise for future clinical trials in pancreatic cancer treatment strategies.

1 min. read

Text message tool addresses ‘time toxicity’ for cancer patients

Image: iStock/andreswd

Text message tool addresses ‘time toxicity’ for cancer patients

In pilot study from Penn Medicine, patients saved over an hour of time at every treatment visit using digital technology.

Developing a tiny anticancer weapon

Image: iStock/Bahaa_Aladdin

Developing a tiny anticancer weapon

Penn Medicine researchers have developed tumor-homing nanosized particles that trigger cancer cell self-destruction in preclinical tests.

New tool puts reproductive risk for BRCA carriers into perspective

Image: iStock/baona

New tool puts reproductive risk for BRCA carriers into perspective

A team at Penn Medicine has created a resource to help inform reproductive counseling for cancer gene mutation carriers.

Generic platinum chemotherapy shortages did not increase deaths

Image: iStock/SeventyFour

Generic platinum chemotherapy shortages did not increase deaths

A national data analysis finds that short-term mortality was not impacted by the shortage for patients with advanced cancers.

Keto diet metabolite may power up CAR T cells to kill cancer

Image: iStock/Naeblys

Keto diet metabolite may power up CAR T cells to kill cancer

Laboratory studies reveal a potentially low-tech intervention to improve personalized cell therapy.

Single-dose gene therapy is potentially life-changing for adults with hemophilia B

Image: iStock/Alena Butusava

Single-dose gene therapy is potentially life-changing for adults with hemophilia B

Based on the results of this study, which recorded a 71% reduction in bleeding episodes, the FDA has approved the single-infusion gene therapy.

Gene therapy trial sees massive improvement in vision

Image: iStock/murat4art

Gene therapy trial sees massive improvement in vision

Patients with a rare disease affecting their sight have experienced quick vision improvements that sustained for the full yearlong Penn Medicine study, with some experiencing a 10,000-fold improvement in their vision.

Combo immunotherapy produces distinct waves of cancer-fighting T cells

Image: iStock/Andrea Danti

Combo immunotherapy produces distinct waves of cancer-fighting T cells

Researchers from Penn’s Abramson Cancer Center have found that a novel tool that tracks immune health over time has revealed new insights on immune cell activation.